India
· Delayed Price · Currency is INR Artemis Medicare Services Statistics
Total Valuation
NSE:ARTEMISMED has a market cap or net worth of INR 35.88 billion. The enterprise value is 35.39 billion.
| Market Cap | 35.88B |
| Enterprise Value | 35.39B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
NSE:ARTEMISMED has 138.93 million shares outstanding. The number of shares has increased by 8.88% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 138.93M |
| Shares Change (YoY) | +8.88% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 2.55% |
| Owned by Institutions (%) | 1.98% |
| Float | 26.47M |
Valuation Ratios
The trailing PE ratio is 52.81 and the forward PE ratio is 38.57. NSE:ARTEMISMED's PEG ratio is 0.88.
| PE Ratio | 52.81 |
| Forward PE | 38.57 |
| PS Ratio | 3.89 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 4.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.88 |
Enterprise Valuation
| EV / Earnings | 47.97 |
| EV / Sales | 3.84 |
| EV / EBITDA | 23.08 |
| EV / EBIT | 32.04 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | n/a |
| Interest Coverage | 3.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.39% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.63M |
| Profits Per Employee | 370,548 |
| Employee Count | 1,991 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.23% in the last 52 weeks. The beta is 0.28, so NSE:ARTEMISMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +40.23% |
| 50-Day Moving Average | 260.01 |
| 200-Day Moving Average | 280.43 |
| Relative Strength Index (RSI) | 42.70 |
| Average Volume (20 Days) | 105,177 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ARTEMISMED had revenue of INR 9.22 billion and earned 737.76 million in profits. Earnings per share was 4.89.
| Revenue | 9.22B |
| Gross Profit | 2.02B |
| Operating Income | 1.10B |
| Pretax Income | 992.39M |
| Net Income | 737.76M |
| EBITDA | 1.46B |
| EBIT | 1.10B |
| Earnings Per Share (EPS) | 4.89 |
Balance Sheet
The company has 3.75 billion in cash and 3.20 billion in debt, giving a net cash position of 546.28 million or 3.93 per share.
| Cash & Cash Equivalents | 3.75B |
| Total Debt | 3.20B |
| Net Cash | 546.28M |
| Net Cash Per Share | 3.93 |
| Equity (Book Value) | 7.99B |
| Book Value Per Share | 50.55 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 21.88%, with operating and profit margins of 11.98% and 8.00%.
| Gross Margin | 21.88% |
| Operating Margin | 11.98% |
| Pretax Margin | 10.76% |
| Profit Margin | 8.00% |
| EBITDA Margin | 15.85% |
| EBIT Margin | 11.98% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.88% |
| Shareholder Yield | -8.71% |
| Earnings Yield | 2.06% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Sep 23, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |